Sera-scandia A/S
Public limited companyCVR 14605185BallerupActive
Sera-scandia A/S is a public limited company, based in Ballerup, active in manufacture of pharmaceutical preparations, founded in 1990. The company went from a profit in 2024 to a loss of DKK 7.8m in 2025. 4 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 10% (2024 → 2025), to DKK 40.6m.
- Net profit went from a profit of DKK 2.2m to a loss of DKK 7.8m (2024 → 2025).
- Equity fell 8% (2024 → 2025), to DKK 272.1m.
Employees
- 1 fewer employees than a year earlier: 16 (08/2026) against 17 (08/2025).
Management and owners, last 24 months
- New in management: Christian Lykkehus Sørensen (board member, 19/06/2025) and Troels Zakarias Glahn Kristiansen (ceo, 01/10/2025).
- Stepped down: Stefan Bødtker Michelsen (director, 01/10/2025) and Stefan Bødtker Michelsen (board member, 15/05/2025).
Registrations, last 24 months
- 01/10/2026: Moved to Borupvang 3, 1, 2750 Ballerup
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | 143,059 | 242,301 | not stated | not stated | not stated | not stated | – |
| Gross profit | 7,379 | 28,715 | 46,880 | 41,875 | 36,945 | 40,586 | +9.9% |
| Operating profit (EBIT) | −12,281 | 9,636 | 23,819 | 6,765 | 1,033 | −14,499 | −1,503.6% |
| Profit before tax | −15,867 | 17,240 | 18,938 | 6,151 | 10,475 | −1,023 | −109.8% |
| Net profit | −16,558 | 16,081 | 11,427 | 2,988 | 2,203 | −7,801 | −454.1% |
| Total assets | 188,723 | 231,516 | 334,959 | 473,644 | 420,214 | 435,283 | +3.6% |
| Equity | 50,297 | 62,020 | 83,114 | 291,439 | 295,655 | 272,104 | −8% |
| Liabilities | 138,368 | 169,434 | 245,312 | 181,934 | 124,257 | 162,043 | +30.4% |
| Cash and cash equivalents | 11,338 | 13,867 | 30,873 | 20,721 | 17,819 | 19,876 | +11.5% |
| Average number of employees | 186 | 176 | 274 | 273 | 231 | 226 | −2.2% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 10/07/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 01/07/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 17/07/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 10/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 20/07/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 15/07/2021 | The group | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 639of 69,742 Better than 99% | No. 781of 69,964 Better than 99% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 4of 36 Better than 91% | No. 2of 37 Better than 97% |
| Companies that are at least 30 years old10,276 companies in the comparison | No. 1,744of 10,152 Better than 83% | No. 606of 10,275 Better than 94% |
| All companies of type A/S18,025 companies in the comparison | No. 3,482of 17,786 Better than 80% | No. 1,128of 18,024 Better than 94% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Sera-scandia A/SDKK 40.6m
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Sera-scandia A/S−DKK 7.8m
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Sera-scandia A/SDKK 272.1m
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Sera-scandia A/S16
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Danbiotech Inc.100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Troels Zakarias Glahn Kristiansen | CEO | 01/10/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Ole Bødtker Nielsen | Chair of the board | 22/09/2020 |
| Nicolas Bødtker Nielsen | Board member | 21/03/2023 |
| Christian Lykkehus Sørensen | Board member | 19/06/2025 |
- Founders
- Victor Christoffersen ApS
Former management (18)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| John Ole Eskildsen | Director | 01/10/1990 | 31/08/2006 |
| Victor Christoffersen | Director | 01/10/1990 | 27/03/1991 |
| Ellen Michelsen Westermann | Director | 01/10/1990 | 19/08/1994 |
| John Ole Eskildsen | Board member | 03/09/2002 | 31/08/2006 |
| Søren Kjeld Christensen | Board member | 03/09/2002 | 16/09/2008 |
| Ole Bødtker Nielsen | Chair of the board | 03/09/2002 | 01/04/2018 |
| Stefan Bødtker Michelsen | Board member | 01/09/2006 | 11/05/2020 |
| Stefan Bødtker Michelsen | Director | 01/09/2006 | 11/05/2020 |
| Christian Lykkehus Sørensen | Board member | 16/09/2008 | 31/03/2018 |
| Christian Lykkehus Sørensen | Chair of the board | 01/04/2018 | 11/05/2020 |
| Nicolas Bødtker Nielsen | Board member | 01/04/2018 | 11/05/2020 |
| Henrik Selchau Poulsen | Liquidator | 04/06/2020 | 05/08/2020 |
| Christian Lykkehus Sørensen | Chair of the board | 05/08/2020 | 22/09/2020 |
| Stefan Bødtker Michelsen | Director | 05/08/2020 | 01/10/2025 |
| Stefan Bødtker Michelsen | Board member | 05/08/2020 | 15/05/2025 |
| Nicolas Bødtker Nielsen | Board member | 05/08/2020 | 22/09/2020 |
| Jørn Martin Bank | Board member | 22/09/2020 | 16/12/2021 |
| Jørn Martin Bank | Deputy chair | 17/12/2021 | 01/11/2023 |
Signing rule: Selskabet tegnes af formanden for bestyrelsen eller to medlemmer af bestyrelsen i forening.
Address and production units
1 active production unitsBorupvang 3
2750 Ballerup
Ballerup Municipality · Postcode 2750
Other companies at the address (4)
- Plus1 Tandlægeklinik København ApSDental practice activities
- Odu Denmark ApSManufacture of other electrical equipment
- BioNordic A/SManufacture of pharmaceutical preparations
- NeXXerum ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Sera Scandia A/S | Borupvang 3, 1, 2750 Ballerup | 16 | 1028121209 |
Purpose
Selskabets formål er at drive handel og industri samt efter bestyrelsens beslutning udøve enhver virksomhed i forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
66 registered events20262 changesaddress 1 · accounts 1
- AddressMoved to Borupvang 3, 1, 2750 Ballerup
- AccountsAnnual report for 2025 published
20255 changesmanagement 4 · accounts 1
- ManagementTroels Zakarias Glahn Kristiansen appointed ceo
- ManagementStefan Bødtker Michelsen stepped down as director
- AccountsAnnual report for 2024 published
- ManagementChristian Lykkehus Sørensen appointed board member
- ManagementStefan Bødtker Michelsen stepped down as board member
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20234 changesmanagement 2 · accounts 1 · address 1
- ManagementJørn Martin Bank stepped down as deputy chair
- AccountsAnnual report for 2022 published
- AddressMoved to Automatikvej 1, 2860 Søborg
- ManagementNicolas Bødtker Nielsen appointed board member
20222 changesaddress 1 · accounts 1
- AddressMoved to Automatikvej 1, 2860 Søborg
- AccountsAnnual report for 2021 published
20213 changesmanagement 2 · accounts 1
- ManagementJørn Martin Bank appointed deputy chair
- ManagementJørn Martin Bank stepped down as board member
- AccountsAnnual report for 2020 published
202016 changesmanagement 12 · status 2 · address 2
- ManagementOle Bødtker Nielsen appointed chair of the board
- ManagementJørn Martin Bank appointed board member
- ManagementNicolas Bødtker Nielsen stepped down as board member
- ManagementChristian Lykkehus Sørensen stepped down as chair of the board
- StatusStatus changed to active
- AddressMoved to Nordre Strandvej 119F, 2, 3150 Hellebæk
- ManagementStefan Bødtker Michelsen appointed director
- ManagementNicolas Bødtker Nielsen appointed board member
- ManagementStefan Bødtker Michelsen appointed board member
- ManagementChristian Lykkehus Sørensen appointed chair of the board
- StatusStatus changed to under compulsory dissolution
- ManagementNicolas Bødtker Nielsen stepped down as board member
- ManagementChristian Lykkehus Sørensen stepped down as chair of the board
- ManagementStefan Bødtker Michelsen stepped down as director
- ManagementStefan Bødtker Michelsen stepped down as board member
- AddressMoved to Langelinie Allé 17, 2100 København Ø
20185 changesaddress 1 · management 4
- AddressMoved to Nordre Strandvej 119F, 3150 Hellebæk
- ManagementNicolas Bødtker Nielsen appointed board member
- ManagementChristian Lykkehus Sørensen appointed chair of the board
- ManagementOle Bødtker Nielsen stepped down as chair of the board
- ManagementChristian Lykkehus Sørensen stepped down as board member
20151 changeaddress 1
- AddressMoved to Nordre Strandvej 119F, 3150 Hellebæk
20141 changeownership 1
- OwnershipDanbiotech Inc. registered as owner (100%)
20121 changecapital 1
- CapitalShare capital changed from 21,000,000 DKK to 40,000,000 DKK
20091 changeaddress 1
- AddressMoved to Strandvejen 203, 2900 Hellerup
20083 changesmanagement 2 · industry 1
- ManagementChristian Lykkehus Sørensen appointed board member
- ManagementSøren Kjeld Christensen stepped down as board member
- IndustryIndustry changed to Manufacture of pharmaceutical preparations (212000)
20071 changecapital 1
- CapitalShare capital changed from 15,000,000 DKK to 21,000,000 DKK
20064 changesmanagement 4
- ManagementStefan Bødtker Michelsen appointed director
- ManagementStefan Bødtker Michelsen appointed board member
- ManagementJohn Ole Eskildsen stepped down as board member
- ManagementJohn Ole Eskildsen stepped down as director
20032 changesaddress 2
- AddressMoved to Strandvejen 171, 2900 Hellerup
- AddressMoved to Strandvejen 171,
20026 changesname 1 · address 1 · management 3 · capital 1
- NameName changed from SERA-SCANDIA ApS to SERA-SCANDIA A/S
- AddressMoved to Strandvejen 17A,
- ManagementJohn Ole Eskildsen appointed board member
- ManagementOle Bødtker Nielsen appointed chair of the board
- ManagementSøren Kjeld Christensen appointed board member
- CapitalShare capital changed from 125,000 DKK to 15,000,000 DKK
19971 changecapital 1
- CapitalShare capital changed from 80,000 DKK to 125,000 DKK
19941 changemanagement 1
- ManagementEllen Michelsen Westermann stepped down as director
19912 changesname 1 · management 1
- NameName changed from VICH 2604 ApS to SERA-SCANDIA ApS
- ManagementVictor Christoffersen stepped down as director
19904 changesfounded 1 · management 3
- FoundedRegistered as VICH 2604 ApS
- ManagementVictor Christoffersen appointed director
- ManagementEllen Michelsen Westermann appointed director
- ManagementJohn Ole Eskildsen appointed director
Related companies
Same people in management
- Danish Crown A/Svia Victor Christoffersen
- Vestas Wind Systems A/Svia Victor Christoffersen
- Hofor A/Svia Victor Christoffersen
- Ørsted Services A/Svia Victor Christoffersen
- Saxo Bank A/Svia Victor Christoffersen
- Ørsted Bioenergy & Thermal Power A/Svia Victor Christoffersen
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.